| P50 | author | Ah-Ng Kong | Q88994223 |
| P2093 | author name string | Jae Young So | |
| | Nanjoo Suh | |
| | Yong Lin | |
| | Chung S Yang | |
| | Weichung Joe Shih | |
| | Mao-Jung Lee | |
| | Amanda K Smolarek | |
| | Kenneth Reuhl | |
| | Brenda Burgess | |
| | Guangxun Li | |
| | Yu-Kuo Chen | |
| P2860 | cites work | Gamma-tocopherol supplementation inhibits protein nitration and ascorbate oxidation in rats with inflammation | Q42528104 |
| | γ‐Tocopherol, but not α‐tocopherol, decreases proinflammatory eicosanoids and inflammation damage in rats | Q44425145 |
| | Estrogen receptor alpha binds to peroxisome proliferator-activated receptor response element and negatively interferes with peroxisome proliferator-activated receptor gamma signaling in breast cancer cells | Q46689391 |
| | HER2 amplification ratios by fluorescence in situ hybridization and correlation with immunohistochemistry in a cohort of 6556 breast cancer tissues | Q47612892 |
| | Prostate Cancer and Supplementation With α-Tocopherol and β-Carotene: Incidence and Mortality in a Controlled Trial | Q61773226 |
| | The alpha-tocopherol, beta-carotene lung cancer prevention study: design, methods, participant characteristics, and compliance. The ATBC Cancer Prevention Study Group | Q72522275 |
| | Effects of supplemental alpha-tocopherol and beta-carotene on colorectal cancer: results from a controlled trial (Finland) | Q73715104 |
| | Global cancer statistics | Q22241238 |
| | Vitamin E: function and metabolism | Q28138332 |
| | Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial | Q28182767 |
| | Vitamin E and cancer: An insight into the anticancer activities of vitamin E isomers and analogs | Q28282070 |
| | The chemistry and antioxidant properties of tocopherols and tocotrienols | Q28291396 |
| | Cancer chemoprevention with dietary phytochemicals | Q29617743 |
| | Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT) | Q29619860 |
| | Analysis of multiple metabolites of tocopherols and tocotrienols in mice and humans | Q33804986 |
| | A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients. | Q33986245 |
| | gamma-tocopherol, the major form of vitamin E in the US diet, deserves more attention | Q34103259 |
| | Lifestyle as risk factor for cancer: Evidence from human studies | Q34346770 |
| | Vitamin E and cancer | Q34650031 |
| | δ-tocopherol is more active than α - or γ -tocopherol in inhibiting lung tumorigenesis in vivo | Q34764111 |
| | The European perspective on vitamin E: current knowledge and future research | Q34905197 |
| | gamma-tocopherol and its major metabolite, in contrast to alpha-tocopherol, inhibit cyclooxygenase activity in macrophages and epithelial cells | Q35307368 |
| | Vitamin E and breast cancer prevention: current status and future potential | Q35572451 |
| | New perspectives on vitamin E: gamma-tocopherol and carboxyelthylhydroxychroman metabolites in biology and medicine | Q35633130 |
| | Chemopreventive activity of vitamin E in breast cancer: a focus on γ- and δ-tocopherol | Q35671133 |
| | Dietary tocopherols inhibit cell proliferation, regulate expression of ERα, PPARγ, and Nrf2, and decrease serum inflammatory markers during the development of mammary hyperplasia | Q36031004 |
| | gamma-tocopherol traps mutagenic electrophiles such as NO(X) and complements alpha-tocopherol: physiological implications | Q36083550 |
| | Gamma-tocopherol detoxification of nitrogen dioxide: superiority to alpha-tocopherol | Q36130067 |
| | Dietary cancer-chemopreventive compounds: from signaling and gene expression to pharmacological effects | Q36145133 |
| | Gamma-tocopherol-enriched mixed tocopherol diet inhibits prostate carcinogenesis in TRAMP mice | Q36425851 |
| | Dietary cancer chemopreventive agents - targeting inflammation and Nrf2 signaling pathway | Q37303983 |
| | Mixed tocopherols prevent mammary tumorigenesis by inhibiting estrogen action and activating PPAR-gamma | Q37366222 |
| | Peroxisome proliferator-activated receptor gamma in bladder cancer: a promising therapeutic target | Q37471196 |
| | Comparative study of human and rat mammary tumorigenesis. | Q37809123 |
| | Molecular pathways for cancer chemoprevention by dietary phytochemicals. | Q37866180 |
| | Vitamin E as an in vitro and in vivo antioxidant | Q38776458 |
| | Gemini vitamin D analog suppresses ErbB2-positive mammary tumor growth via inhibition of ErbB2/AKT/ERK signaling | Q39725359 |
| | Host factors affecting the growth of carcinogen-induced rat mammary carcinomas: a review and tribute to Charles Brenton Huggins. | Q39847926 |
| | Oxidative stress, tumor microenvironment, and metabolic reprogramming: a diabolic liaison | Q42178112 |
| P433 | issue | 11 | |
| P304 | page(s) | 1310-1320 | |
| P577 | publication date | 2012-09-10 | |
| P1433 | published in | Cancer Prevention Research | Q2665103 |
| P1476 | title | Dietary administration of δ- and γ-tocopherol inhibits tumorigenesis in the animal model of estrogen receptor-positive, but not HER-2 breast cancer | |
| P478 | volume | 5 | |